New award for clozapine tablets with mylan. Ordering period is march 4, 2023 to march 3, 2024 with four one-year options

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79723D0015
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 92% complete
IDV ceiling
$8,346,790.65
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The VA National Acquisition Center awarded a single-award Indefinite Delivery Contract to Mylan Pharmaceuticals Inc. for clozapine tablets with a ceiling of $8,346,790.65 on March 4, 2023. The ordering period runs from March 4, 2023 through March 3, 2024, with four one-year options extending ultimate completion to March 3, 2027. Performance is nationwide, supplying clozapine tablets to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract incorporates a diversity, equity, and inclusion clause. The originating solicitation, posted August 3, 2022 with responses due August 31, 2022, sought a pharmaceutical supplier for clozapine, a prescription medication supporting veteran mental health care and broader federal health agency needs. An estimated 19,000 or more bottles will be provided annually under the five-year contract term.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00009 · Incorporate DEI clause for mylan pharmaceuticals. $0
Add Subcontract Plan P00008 · 2026 subcontracting plan effective january 1, 2026 through december 31, 2026 for clozapine tablets with mylan pharmaceuticals. $0
Exercise an Option P00007 · Exercise option year 3 effective march 4, 2026 through march 3, 2027 for clozapine tablets with mylan pharmaceuticals. Prices remain unchanged. $0
Exercise an Option P00006 · Exercise option year 2 effective march 4, 2025 through march 3, 2026 for clozapine tablets with mylan pharmaceuticals. Prices remain unchanged. $0
Add Subcontract Plan P00005 · 2025 subcontracting plan $0
Supplemental Agreement for work within scope P00004 · Change in cost recovery fee submittal and sales reporting procedures $0
Exercise an Option P00003 · Exercise option year 1 effective march 4, 2024 through march 3, 2025 for clozapine tablets with mylan pharmaceuticals, INC. Prices remain unchanged. $0
Add Subcontract Plan P00002 · Incorporating 2024 subcontracting plan for clozapine tablets with mylan pharmaceuticals, INC. Effective 1/1/2024 through 12/31/2024. $0
Other Administrative Action P00001 · Incorporating dscsa for clozapine tablets with mylan pharmaceuticals, INC. Effective 5/15/2023. $0
Original award $0

Quick answers

Who was awarded contract 36E79723D0015?

36E79723D0015 was awarded to Mylan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on March 4, 2023.

How much is contract 36E79723D0015 worth?

36E79723D0015's own ceiling is $8,346,791.

Who can order from contract 36E79723D0015?

36E79723D0015 is a single award indefinite delivery contract.

Was contract 36E79723D0015 competed?

The extent of competition for 36E79723D0015 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV